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OBJECTIVE — Serial measurements of the fetal abdominal circumference have been used to
guide metabolic management of pregnancies complicated by gestational diabetes mellitus
(GDM).Areductioninthenumberofrepeatultrasoundexaminationswouldsaveresources.Our
purpose was to determine the number of serial abdominal circumference measurements per
patient necessary to reliably predict the absence of fetal overgrowth.
RESEARCHDESIGNANDMETHODS — WomenwhohadGDMwereaskedtoreturn
for repeat ultrasound at 3- to 4-week intervals starting at initiation of care (mean 26.9  5.7
weeks). Maternal risk factors associated with fetal overgrowth were determined.
RESULTS — A total of 4,478 ultrasound examinations were performed on 1,914 subjects
(2.3  1.2 per pregnancy). Of the 518 women with fetal abdominal circumference 90th
percentile,itwasdiagnosedin73.9%withtheﬁrstultrasoundexaminationatentryandin13.1%
withthesecondultrasoundexamination.Ofthefetuses,85.9and86.9%ofthefetuseswereborn
non-large for gestational age (LGA) when abdominal circumference was 90th percentile at
24–27 weeks and 28–32 weeks, respectively, and 88.0% were born non-LGA when both scans
showed normal growth. For those women who had no risk factors for fetal overgrowth (risk
factors:BMI30kg/m
2,historyofmacrosomia,andfastingglucose100mg/dl),theaccuracy
of prediction of a non-LGA neonate was 90.0, 89.5, and 95.2%. The predictive ability did not
increase with more than two normal scans.
CONCLUSIONS — The yield of sonographic diagnosis of a large fetus drops markedly after
the ﬁnding of a fetal abdominal circumference 90th percentile on two sonograms, which
excludes with high reliability the risk of a LGA newborn. The ability was enhanced in women
who had no risk factors for neonatal macrosomia.
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T
he recommendations for diagnosis
and treatment of gestational diabe-
tes mellitus (GDM) of the Fifth In-
ternational Workshop-Conference on
Gestational Diabetes Mellitus (1) suggest
consideration of fetal growth patterns to
guidemetabolicmanagementofpregnant
women with GDM. Estimation of fetal
weight, particularly at term and in fetuses
with high neonatal weight, is not as pre-
cise as is desirable (2). However, enlarged
size (3–6) and accelerated growth veloc-
ity of the fetal abdominal circumference
in the third trimester is known to predict
large-for-gestational-age (LGA) birth
weight (7). Previous randomized studies
have demonstrated that measurement of
the fetal abdominal circumference
throughout pregnancy in women who
have GDM is useful to identify pregnan-
cies at high risk for fetal overgrowth and
therefore in need of intensiﬁed interven-
tion (8–11). On the other side, relaxed
glycemic goals had been allowed in
women with sonographic evidence of
normal fetal growth. Besides saving insu-
lin therapy, this approach reduced the
rate of fetal growth restriction in the fe-
tuses of those women. Published proto-
cols for fetal growth–based management
require sonographic determination of fe-
tal abdominal circumference at the time
of diagnosis of GDM (8–11) followed by
repeat examinations at 2 (11)- to 4-week
intervals(9,10).Serialsonographicexam-
inations are costly and require the time
and expertise of experienced ultrasonog-
raphers and/or physicians.
The purpose of our study was to de-
termine the number of sequential ultra-
soundexaminationsnecessarynottomiss
development of an enlarged abdominal
circumference during pregnancy and to
assurealowriskforaLGAneonatewitha
great degree of certainty when the scans
suggest normal fetal growth. In addition,
we wished to evaluate whether the ab-
sence of maternal risk factors for neonatal
macrosomia would enhance the accuracy
of the ultrasound examination predicting
a non-LGA neonate.
RESEARCH DESIGN AND
METHODS— Women with historical
risk factors for diabetes (e.g., family his-
tory of diabetes, GDM in a prior preg-
nancy,andobesity)weretestedintheﬁrst
trimester. All other patients were tested
for GDM either at 24–28 weeks or when-
ever risk factors (e.g., glycosuria or sono-
graphic suspicion of macrosomia) ﬁrst
appearedduringthecourseofpregnancy.
In 20% of the women an elevated 50-g
glucose challenge test with a 1-h value
140 mg/dl preceded the oral glucose
tolerance test (OGTT).
GDM was deﬁned by the criteria of
Carpenter and Coustan (12). Data for
women who had GDM and who attended
the Diabetes Prenatal Care Clinic of the
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Medical Center between 1 January 2001
and 31 December 2007 were analyzed.
These data had been entered prospec-
tively. This study was approved by the
ethics committee of the Charite ´ Hospital,
Humboldt University of Berlin. Study in-
clusion criteria were 1) documented
GDM, 2) accurate gestational age, con-
ﬁrmed by an ultrasound examination be-
fore 20 weeks of gestation, 3) a singleton
pregnancy, 4) a fetal biometry deter-
mined by ultrasound at initiation of ther-
apy for GDM, 5) at least one repeat
ultrasound biometry examination, 6) the
absence of fetal anomalies identiﬁed at
birth, and 7) availability of data regarding
maternal obstetrical history and
anthropometry.
Care for GDM was delivered accord-
ing to German guidelines for diagnosis
and therapy of GDM (13). The latter were
largely derived from the recommenda-
tions of the Fourth International Work-
shop-Conference on Gestational Diabetes
Mellitus (14). All women were given in-
dividualized diets for the treatment of di-
abetes in pregnancy. Those requiring
treatment with only diet were instructed
toself-monitorbloodglucosefourtimesa
day (fasting and 2-h postprandial) twice a
week using memory-based reﬂectance
meters (Advantage Glucose Meter, Roche
Diagnostics, Mannheim, Germany).
Women with sporadically elevated glu-
cose values but not meeting the criteria
for insulin therapy were tested more of-
ten. Insulin therapy was recommended
when fasting glucose values repeatedly
were 90 mg/dl (5.0 mmol/l) and/or 2-h
postprandial values were 120 mg/dl
(6.6 mmol/l). The term “proﬁle at entry,”
which is used in Table 1 and 2, includes
the mean of all fasting glucose measure-
ments and the mean of the postprandial
glucosemeasurementsoftheglucosepro-
ﬁles performed by the women within the
ﬁrst 2 weeks after diet education (before
initiation of insulin therapy).
Ultrasound examinations
An initial ultrasound examination with
complete fetal biometry was scheduled at
the ﬁrst visit for diabetes care and at 3- to
4-week intervals thereafter, in conjunc-
tion with clinic visits. Examinations were
performed by physicians experienced in
fetal ultrasound. The fetal abdominal cir-
cumferencewasmeasuredinthestandard
cross-sectional view of the abdomen. An
abdominal circumference 90th percen-
tile for gestational age (15) was consid-
ered predictive of fetal macrosomia (this
term is used interchangeably with en-
larged abdominal circumference in the
rest of this report). All scans were classi-
ﬁed into ﬁve categories according to
gestational ages at performance: 24,
24/0–27/6, 28/0–31/6, 32/0–35/6, and
36/0–39/6weeks.LGAneonateswerede-
ﬁned as those whose birth weight was
90thpercentileforgestationalageusing
astandardGermanbirthweightreference
(16) (LGA is used interchangeably with
neonatal macrosomia).
Statistical analysis
Differences between pregnant women
whose fetuses had at least one abdominal
circumference 90th percentile during
pregnancy and those with no fetal abdomi-
nal circumference 90th percentile were
tested for statistical signiﬁcance by the
Mann-Whitney U test (continuous vari-
ables)orby
2analysis(forcategoricalvari-
ables). Data are presented as means  SD.
The frequency of newly diagnosed
abdominal circumference 90th percen-
tile for each ultrasound examination and
the cumulative detection rate were deter-
mined for each additional ultrasound ex-
amination. To evaluate whether the
absence of maternal risk factors improves
the ability of the sonographic prediction
of a normal-sized baby, forward stepwise
multivariate logistic regression analysis
including all parameters (except delivery
of newborn with birth weight 90th per-
centile) was performed, putting those in-
dependent variables found to be
statistically signiﬁcantly associated with a
fetal abdominal circumference 90th
percentile in the univariate analyses (Ta-
ble 1) into the multivariable model. Con-
tinuous variables were dichotomized
according to established clinical thresh-
olds(e.g.,BMI30kg/m
2andgestational
age at diagnosis 24 weeks) and/or sta-
tistical considerations (fasting glucose at
ﬁrst proﬁle 100 mg/dl). Determination
of the prevalence of LGA was done by fre-
quency analysis. All statistical analyses
were performed with the statistical pro-
gram SPSS 16.0 (SPSS, Chicago, IL). Sta-
tistical signiﬁcance was set at P  0.05.
RESULTS— A total of 1,914 women
wereeligibleforinclusioninthestudy.An
OGTT was performed in 32.7% because
of historical risk factors, in 33.9% as part
of routine screening, and in 33.4% for
risk factors ﬁrst noted during pregnancy
(e.g., excessive weight gain or excessive
fetal growth). Patient demographics are
reported in Table 1. Insulin therapy was
started at a mean of 25.4  10.6 weeks of
gestation.
A total of 4,478 ultrasound examina-
tions were reviewed. The mean  SD
number of examinations performed per
patient was 2.3  1.2 with a range from
two to six scans per patient. The gesta-
tional age at the ﬁrst ultrasound examina-
tion was 26.6  6.5 weeks. In 518
women (27.0%), there was at least one
abdominal circumference measurement
90th percentile during pregnancy,
whereas in 1,399 (73.0%) women, no
fetal abdominal circumference measure-
ment was 90th percentile for gesta-
tionalage.Ofthe518womenwithatleast
one abdominal circumference measure-
ment 90th percentile, 383 (73.9%) of
enlarged fetal abdominal circumferences
were found on the ﬁrst ultrasound exam-
ination, 68 (13.1%) were found on the
secondsonogram,33(6.4%)onthethird,
20 (3.9%) on the fourth, and 14 (2.7%)
on the ﬁfth. Subanalysis in the 318
womenwithoutaneedforinsulintherapy
(an additional 40 women refused ther-
apy) showed very similar percentages:
77.4% found with the ﬁrst scan, 13.8%
with the second scan, 6.3% with the third
scan, and 1.3% with the fourth and ﬁfth
scan each. Figure 1A displays the rate of
identiﬁcation of fetuses whose abdominal
circumference 90th percentile was
identiﬁedattheinitialoreachsubsequent
ultrasound examination. With two se-
quential scans, 87.1% of fetuses with an
abdominal circumference 90th percen-
tile for gestational age were detected (Fig.
1), while a third scan added only 3% new
cases. Women whose fetuses were found
to have an abdominal circumference
90th percentile were of greater parity,
more frequently had a history of GDM
and of neonatal macrosomia in at least
one previous pregnancy, and had
prepregnancy BMIs and fasting glucose
values both at OGTT and throughout the
duration of their current pregnancies that
were signiﬁcantly greater than those of
womenwithnoabdominalcircumference
measurement90thpercentile(Table1).
The multivariable regression analysis
identiﬁed three variables as independent
predictors for development of neonatal
macrosomia: history of LGA newborn,
BMI 30 kg/m
2, and fasting glucose val-
ues100mg/dl(Table2).Afetalabdom-
inal circumference 90th percentile was
less frequently found in the absence of
risk factors (n  1,133; 59.2%) than in
the presence of risk factors for neonatal
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In women without any of these risk fac-
tors, fetal abdominal circumference
90th percentile was more frequently
found with the ﬁrst scan at entry than in
women with the presence of risk factors
(80.2vs.67.8%(Fig.1),andwiththesec-
ond scan 92.2% of all cases of fetal mac-
rosomia had been detected in contrast
with 79.1%. In women without risk fac-
tors the slope of the curve (Fig. 1A) be-
came markedly ﬂat after the second scan,
indicatingthatthereisaminorincreasein
thediagnosticrateofnewlydevelopedab-
dominal circumference 90th percentile
with further ultrasound examinations.
Gestational age at the ﬁrst scan was not
signiﬁcantly different in women without
orwithriskfactors(26.76.4vs.26.3
6.4 weeks; P  0.2).
The probability of delivering a non-
LGA neonate with an abdominal circum-
ference90thpercentileaccordingtothe
number of ultrasound examinations is
shown in Fig. 1B. Besides in women with
riskfactors,therateofcorrectlypredicted
non-LGA newborns did not further in-
crease when more than two ultrasound
examinations were performed. In women
in whom all ultrasound examinations
showed a normal abdominal circumfer-
ence, the probability was 88.9%, and
probability increased to 92.2% in the ab-
sence of maternal risk factors for neonatal
macrosomia (Table 3). Among women
with no risk factors, the probability of a
non-LGAneonatewasnotstatisticallysig-
niﬁcantly different between women who
had only two and those who had more
than two fetal abdominal circumference
measurements 90th percentile (P 
0.6). In women with risk factors, the
probability for a non-LGA newborn was
signiﬁcantly lower at all gestational ages
and combination of scans. The sensitivity
to predict LGA birth weight was 42.4%
Table 1—Maternal demographics and delivery data
Abdominal circumference 90th
percentile
P value None 1
n 1,399 518
Clinical parameter
History of GDM (%) 14.9% 20.7% 0.006
History of macrosomia (%) 10.2% 19.8% 0.0001
Parity 1.9  1.4 2,3  1.6 0.0001
Age (years) 30.6  5.6 31.8  5.3 0.0001
Prepregnancy BMI (kg/m
2) 27.0  5.8 28.9  6.6 0.0001
BMI 30 kg/m
2 (%) 26.6 36.6 0.0001
Delivery of newborn with birth weight
90th percentage (%) 11.1 37.4 0.0001
Measures of maternal glucose
Gestational age at diagnosis 27.0  5.3 26.7  6.6 0.218
OGTT fasting (mg/dl) 92.1  20,8 94.1  24.0 0.0001
1 h 194.4  36.2 198.0  34.7 0.66
2 h 146.3  40,4 150.6  40.0 0.055
Glucose on initiation of treatment for GDM:
Fasting of proﬁle at entry (mg/dl) 83.1  14.4 87.1  16.6 0.0001
Postprandial of proﬁle at entry (mg/dl) 117.4  20.7 119.4  21.5 0.17
Insulin use (%) 18.9 22.1 0.7
Delivery
Gestational age at delivery (weeks) 38.8  1.8 38.3  2.0 0.001
Cesarean section (%) 14.4 21.1 0.001
Birth weight(g) 3,309.8  550.8 3,639.6  559.4 0.001
LGA (%) 18.4 38.1 0.0001
SGA (%) 9.2 2.7 0.0001
Data are means  SD or %. LGA, birthweight 90th percentile; small for gestational age (SGA), birthweight
10th percentile.
Figure 1—A: Cumulative detection rate of an abdominal circumference 90th percentile in all 518 pregnancies with at least one event of fetal
abdominal circumference 90th percentile according to the number of the scan when abdominal circumference 90th percentile was diagnosed for
the ﬁrst time (50.4% had two, 26.3% had three, 15.3% had four, and 8.1% had ﬁve or six ultrasound examinations). B: Rate of non-LGA newborns
(sensitivity) according to number of scans with abdominal circumference 90th percentile. Data are given for the total population and for women
with and without maternal risk factors (RF).
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percentile at 24–27 weeks, 40.0% at
28–31 weeks, 49.1% at 32–35 weeks,
and 56.6% at 36–39 weeks of gestation.
CONCLUSIONS — An intensive in-
sulin regimen was proven to reduce the
rate of LGA newborns (17); however,
only a minority of women are at risk for
accelerated fetal growth. Since the early
1990s, trials incorporating sonographic
measurement of the fetal abdomen into
the care of women who had GDM have
been reported. Intensiﬁed care, meaning
insulintherapyandahighnumberofglu-
cose proﬁles, was offered only to women
whose ultrasound examinations sug-
gestedacceleratedfetalgrowth.Aremark-
able decrease in newborns with neonatal
macrosomia as well as with growth re-
striction was found among women who
followed the sonographically determined
fetal growth–based plan of management
that incorporated performance of serial
sonogramsfromentrytodeliverytoselect
women in need of intensive care (8–
11,18). Repeated ultrasound examina-
tions are costly and require transfer to an
experienced ultrasonographer. The ques-
tion addressed by the current study is the
number of sequential fetal abdominal cir-
cumference measurements needed to de-
tect all fetuses with a tendency for fetal
overgrowth and to exclude those fetuses
at low risk for being LGA at birth with a
high degree of certainty. The ﬁndings of
our study suggest that the yield of sono-
graphic diagnosis of a large fetus drops
markedly after the ﬁnding of a fetal ab-
dominalcircumference90thpercentile.
The probability of neonatal macrosomia
when both the scan at diagnosis of GDM
and a subsequent scan 3 weeks later
showed normal growth is relatively low.
To be speciﬁc, we found that 74% of
sonographically large babies were diag-
nosed with the ﬁrst scan and 50% of the
remainder with the second ultrasound.
With two consecutive ultrasound ﬁnd-
ings of normal fetal growth, non-LGA ne-
onates of women who had GDM were
predicted with good accuracy. The pre-
dictive ability did not improve with more
scans.Theseﬁndingsareconsistentwitha
previous study showing that multiple
measurements in the third trimester seem
to provide little improvement in predic-
tion of birth weight compared with a sin-
gle scan (19). When the fetal abdominal
circumference was 90th percentile at
both 24–27 and 28–31 weeks of gesta-
tion, fetal growth stayed normal through-
outtheremainderofpregnancyin88%of
the women. The predictive ability for
non-LGA birth weight of two normal
scans at 24–27 and 28–31 weeks of ges-
tationwasidenticalwiththoseofallscans
with fetal abdominal circumference
90th percentile. Thus, limitation to an
ultrasound examination at time of diag-
nosisofGDMat24–27weeksofgestation
followed by a subsequent scan at 28–31
weeks might be reasonable, particularly
in women with no risk factors for neona-
tal macrosomia.
We identiﬁed three independent ma-
ternal risk factors for predicting an LGA
newborn (history of a previous LGA new-
born, maternal obesity, and a fasting
blood glucose100 mg/dl on the initial
proﬁle after diagnosis of GDM). Consid-
eration of these risk factors seems to be
useful to decide how many additional
scans are necessary to identify pregnan-
ciesatriskforfetalovergrowth.Thenum-
ber of scans needed to detect the majority
of all cases of sonographic fetal over-
growth and the ability to predict normal-
weightneonatesdifferinwomenwithand
without the presence of maternal risk fac-
tors. The prediction of non-LGA birth
weightwasenhancedinwomenwithout
risk factors. In the absence of maternal
risk factors, two normal serial scans in
the early third trimester predict non-
LGA newborns with a reliability of 94%
incomparisonwith79%inwomenwith
risk factors, indicating that there might
be a lower probability that macrosomia
occurs later in pregnancy in low-risk
women.
The major limitation of every study
involving ultrasound is the unsatisfying
reliability of the method per se. Ultra-
sound became an essential tool in obstet-
rics,butunfortunatelytheaccuracyofthe
prediction of birth weight depends on
many factors such as the position of the
fetus, maternal obesity, the timing of the
scan, and others. Even with experienced
ultrasonographers,thereisaconsiderable
interobserver error. Reports of positive
predictive value and sensitivity range
from 52 to 67 and from 55 to 100%, re-
spectively, with a median positive predic-
tive value of 67% and a sensitivity of 62%
(2). This is a problem, particularly in
newborns with high birth weights, be-
cause the percent error seems to increase
with birth weight (20), and this is true for
most variations of formulas used for cal-
culation of estimated fetal weight. When
formulas for composite estimated fetal
weightbasedonthreemeasures,headand
Table 2—Independent risk factors for LGA birth weight in pregnancies with abdominal cir-
cumference<90thpercentileatﬁrstultrasound(n589womenwithatleastoneriskfactors
of 1,443 subjects with maternal data)
OR (95% CI) P value
History of LGA newborn 2.2 (1.2–3.8) 0.004
Prepregnancy BMI 30 kg/m
2 1.6 (1.04–2.5) 0.032
Mean fasting glucose at proﬁle at entry
100 mg/dl (5.5 mmol/l) 2.1 (1.2–3.3) 0.003
Table 3—Ability of an abdominal circumference measurement <90th percentile to predict a
normally grown neonate depending on the gestational age at performance of the scan and the
absence or presence of maternal risk factors for LGA birth weight
Gestational age at abdominal
circumference 90th percentile







All U.S. ( never abdominal
circumference 90th percentile) 88.9 92.2 83.2*
24–27 weeks (n  313) 85.9 90.0 81.8*
28–31 weeks (n  663) 86.9 89.5 79.7*
32–35 weeks (n  817) 87.9 92.5 81.6*
36–39 weeks (n  703) 89.8 93.7 81.0*
In both, 24–27 and 28–31 weeks
(n  280) 88.0 92.5 84.0*
*Signiﬁcantly different from percentage in pregnancies without maternal risk factors.
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length, were compared against those us-
ingabdominalcircumferencealone,asys-
tematic review including 19,000 women
indicated similar overall accuracy (21).
Abdominal circumference measurements
in the third trimester, either the actual
size or the growth velocity, respectively,
have been known for a long time to iden-
tify fetuses with a risk of neonatal macro-
somia in a diabetic pregnancy quite well
(3–7).
Alimitationofourstudydatawasthat
in 10% of the women the reason for per-
forming an OGTT was suspected fetal
macrosomia diagnosed on the routine
scan at 28–32 weeks of gestation. In pa-
tient populations in which all pregnant
women are tested for GDM, the rate of
fetal overgrowth that is detected with the
ﬁrst ultrasound examination on initiation
of diabetes care might be slightly lower. A
practical limitation of our data is that
therearemissingscansinthelongitudinal
ultrasound follow-up. The latter was due
to either women not keeping appoint-
ments or a lack of qualiﬁed sonographers
on a given day or both. However, we can
reasonably infer from our data that addi-
tional fetal ultrasound examinations after
the ﬁrst two fetal ultrasound examina-
tions suggesting normal fetal growth are
unlikely to improve the ability to exclude
theriskoffetalovergrowth.Furthermore,
the absence of maternal risk factors im-
proves the predictive ability. These ﬁnd-
ings await conﬁrmation by randomized
controlled trials.
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